SBIR/STTR Research Award
THE GOAL OF THE PROPOSED PROJECT IS TO DEVELOP AN HIV VACCINE PLATFORM FOR DELIVERY OF HIV ENV IMMUNOGEN THAT PRESENTS ANTIGEN AS NATIVE CONFORMATION
Award amount
$300,000Program and phase
SBIR · Phase IAward year
2022Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Genecure LLC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- LFPEB7MMJCG3
- Solicitation number
- PHS-2022-1
- Topic code
- 101
Research abstract
Novel Platforms for Delivery and/or Expression of HIV Env Immunogens for HIV Vaccines: Efforts towards the development of an efficacious HIV vaccine have focused on improvements in the design of the HIV envelope (Env) immunogen for induction and generation of broadly neutralizing antibody (bNAb) responses and novel platforms for immunogen delivery. The goal of this program is to develop an HIV vaccine platform for delivery of HIV Env immunogens that induce bnAbs and to demonstrate that the vaccine platform/immunogen proposed will elicit a strong and durable NAb HIV Env response.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- High bandwidth all-optical electrophysiology
- Fast multicolor confocal fluorescence imager for neural network mapping
- Advanced culture and recording system for long-term electrophysiological profiling in human brain organoids
- Commercialization Readiness for a Portable PET Insert System for Simultaneous TOF-PET and MR Brain Imaging
- Design and Development of an Advanced Functional MRI Software as Medical Device (SaMD) forClinical Trials and Therapeutic Applications in Neuropsychiatry
Research funding history
2 SBIR/STTR records share this UEI (2001–2022). Reported award amounts total $440,000. Reported amounts are not federal obligations.
Phases: Phase I
Agencies: Department of Health and Human Services